Please login to the form below

Not currently logged in
Email:
Password:

Astellas promotes John Demaree

He becomes vice president of oncology marketing, Americas

Astellas John DemareeAstellas has appointed John Demaree as vice president of oncology marketing for its Americas operations.

In his new role, Demaree will lead the promotion of in-market products, the preparation of product launches and will collaborate with Astellas' partner organisations in the region on marketing strategy.

Demaree was promoted from his position as executive director of oncology marketing, where he oversaw the launch of prostate cancer drug Xtandi (enzalutamide) and promotion of lung cancer therapy Tarceva (erlotinib).

Prior to joining Astellas in 2011, Demaree served as the general manager for oncology business development and alliance management at Abbott, and also brings experience from Eli Lilly and Novartis.

Mark Reisenauer, senior vice president of the oncology business unit for Astellas Americas, said: “Astellas is committed to making a difference in the lives of cancer patients through an emphasis on innovation and R&D.

“We are confident that John's commercial experience in oncology will help us make strides in improving care for the patients we serve.”

22nd July 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Viseven

Viseven is a Global MarTech Services Provider for Pharma and Life Sciences Industries...

Latest intelligence

What does the future hold for clinical trial recruitment?
The past couple of years have raised several aspects of healthcare in the public’s consciousness – and one of the leading ones has been the role of clinical trials in...
When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...